Clinical Trial Update: Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting results for the combination of decitabine and gemtuzumab ozogamicin in acute myeloid leukemia and high-risk myelodysplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Dacogen (decitabine)
• Mylotarg (gemtuzumab ozogamicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2013-08-09